USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Iriver Limited

USPTO PatentsView assignee record - 13 granted patents across 1 technology areas, recorded in grant years 2016–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: H04B (Transmission).

RSS updates for this company

The verdict

According to USPTO PatentsView, Iriver ranks #21,294 of 49,997 tracked US assignees by granted-patent volume, with 13 patents across 1 technology areas.

#21,294
of 49,997 US assignees by volume
2nd percentile
by Innovation Score (13.9/100)
2.1
avg claims per patent
-70%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R21294 · Foreign Corporation #21,294 · 13 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-LOW · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 13 grants
  • MID-PACK #21,294/49,997
  • PHOTO-FINISH Intima Bioscience
  • CPC-NARROW H04B · 1 areas
  • INNOV-LOW 13.9/100
  • CLAIMS-SPARSE 2.1 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DROP -70% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Intima Bioscience, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Iriver’s 13.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Iriver

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Iriver's Innovation Score is 13.9/100 (2nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Iriver?

Each dot is one of Iriver’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Iriver’s own 2.1 claims/patent is at or below the 9.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Iriver vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 12.912.91313.1 0102030 Granted patents (volume) Avg claims / patent Intima Bioscience, Inc. - 13, 25.46Intima BioscienceIntwine Connect, LLC - 13, 18.92Intwine ConnectINVANTI(BEIJING)TECHNOLOGY Co., Ltd. - 13, 1.38Invanti(Beijing)T…Ipevo Corp. - 13, 4.15IpevoIshihara Chemical Co., Ltd. - 13, 8.62Ishihara ChemicalIsteq Group Holding B.V. - 13, 17.92Isteq Group Holdi…Italdesign Giugiaro S.P.A. - 13, 9.38Italdesign Giugia…Iwaki Co., Ltd. - 13, 10.23IwakiIriver Limited - 13, 2.15Iriver
Iriver vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Iriver's grants concentrate

Iriver Limited is a focused PatentsView assignee: 1 CPC subclasses with 7.7% of grants classified under H04B (Transmission). Peak complete grant year is 2018 (5 grants) versus a trough of 2 in 2016. By volume, Iriver sits between Intima Bioscience, Inc. and Iwaki Co., Ltd..

Who files at Iriver's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Iriver holds 13 patents at rank #21,273, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Iriver

By rank, the assignees closest to #21,273 in granted patent volume.

Leaders in H04B (Transmission)

Other assignees with the most granted patents in Iriver's primary technology class.

Iriver's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

14 2nd percentile higher than 2% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

123456 2016201720182020 3
USPTO utility patent grants by year · 2016–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
Iriver Limited patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 2 15.4%
2017 3 23.1%
2018 5 38.5%
2020 3 23.1%

Which technologies does Iriver Limited patent most?

Top 1 of 1 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Iriver Limited's patent record in context - here's where to go next.

  • Iriver Limited's lead technology class is H04B (Transmission), 7.7% of its portfolio - see every assignee active in that class. Explore H04B
  • Ranked #21,294 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Iriver Limited against Intima Bioscience, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 13.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.